Hap Trading, LLC Cerus Corp Call Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$3.38 - $4.22 $7,436 - $9,284	2,200 Added 13.66%	18,300 $0
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.83 $42,875 - $72,875	-12,500 Reduced 43.71%	16,100 $1,000
Q2 2022 Aug 12, 2022	BUY	$4.41 - $5.69 $60,858 - $78,522	13,800 Added 93.24%	28,600 $9,000
Q1 2022 May 12, 2022	BUY	$4.81 - $6.99 $71,188 - $103,452	14,800 New	14,800 $4,000
Q3 2021 Nov 10, 2021	SELL	$4.79 - $6.68 $60,833 - $84,836	-12,700 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$5.35 - $6.35 $67,945 - $80,645	12,700 New	12,700 $3,000
Q1 2021 May 14, 2021	SELL	$5.68 - $7.87 $84,064 - $116,476	-14,800 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.25 - $8.56 $27,825 - $45,368	-5,300 Reduced 26.37%	14,800 $4,000
Q3 2020 Nov 13, 2020	SELL	$5.78 - $7.47 $21,386 - $27,639	-3,700 Reduced 15.55%	20,100 $23,000
Q2 2020 Aug 10, 2020	BUY	$4.5 - $7.02 $107,100 - $167,076	23,800 New	23,800 $36,000

155

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $278M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.